![[CDDF NEW WHITE PAPER: Challenges and Potential Solutions to Advance Global Cancer Drug Development]](https://cddf.org/wp-content/uploads/2026/03/202603_Challenges-and-Potential-Solutions-to-Advance-Global-Cancer-Drug-Development-1080x675.jpg)
[CDDF NEW WHITE PAPER: Challenges and Potential Solutions to Advance Global Cancer Drug Development]
We are delighted to announce that CDDF’s new white paper, Challenges and Potential Solutions to Advance Global Cancer Drug Development, has been published in the journal Therapeutic Innovation & Regulatory Science. This paper reflects on multi-stakeholder...
CDDF Diversity Initiative: In-Person Meeting in Brussels Today
Following several work package meetings over the past 10 months, the final project meeting for the Diversity Initiative is in full swing in Brussels. Our multi-stakeholder working group members and experts have gathered to advance their work on developing and...![[EMA News] Public Consultation: Concept Paper on Guideline Revision on Good Pharmacogenomic Practice](https://cddf.org/wp-content/uploads/2026/03/EMA-News-1080x675.jpg)
[EMA News] Public Consultation: Concept Paper on Guideline Revision on Good Pharmacogenomic Practice
🔔📢The European Medicines Agency has published for public consultation: a Concept paper on the guideline revision on good pharmacogenomic practice. Since its initial publication in 2018, the guideline on good pharmacogenomic practice has played a crucial role in...